SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-012432
Filing Date
2020-05-15
Accepted
2020-05-15 09:30:40
Documents
3
Period of Report
2020-05-14
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea121884-8k_immucellcorp.htm 8-K 23704
2 PRESS RELEASE OF IMMUCELL CORPORATION DATED MAY 14, 2020 ea121884ex99-1_immucellcorp.htm EX-99.1 11910
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4121
  Complete submission text file 0001213900-20-012432.txt   42531
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12934 | Film No.: 20881238
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences